Information & sources regarding our department
Sub-pages for the medical specialties in the department
Educational resources for CME, PGME, and UME
Details on funding, guidelines & support for research
Resources for onboarding new department members
Support Resources for the Department of Medicine COVID-19 Response
Resources & tools for department members
Branding, templates and communications archives
Images and Files for Nephrology.
Posted October 4, 2017 by DomAdmin
Posted August 2, 2018 by DomAdmin
Posted January 9, 2020 by DomAdmin
Posted April 11, 2019 by DomAdmin
Posted December 12, 2018 by DomAdmin
Posted December 19, 2016 by DomAdmin
Posted May 12, 2017 by DomAdmin
Posted April 11, 2018 by DomAdmin
Posted May 24, 2017 by DomAdmin
Clinical Associate Professor
Phone: 403-220-6376 | Fax: 403-210-9717
Zone Clinical Section Chief – Nephrology, Professor
Phone: 403-220-2418 | Fax: 403-210-3949
Daniel A. Muruve is a Professor of Medicine in the Department of Medicine at the University of Calgary. He is a member of the Immunology Research Group in the Snyder Institute for Chronic Diseases. Dr. Muruve holds a Senior Clinical Scholar Award from the Alberta Heritage Foundation for Medical Research and a Canada Research Chair in Personalized Medicine, Inflammation and Kidney Disease. Dr. Muruve is a general nephrologist in the Calgary region of Alberta Health Services. He is the Section Chief for Nephrology in the Department of Medicine, University of Calgary and Medical Director of the Southern Alberta Renal Program for Alberta Health Services.
Dr. Muruve’s research expertise is in the areas of innate immunity, inflammation and kidney disease. Currently, his research program examines the role of the innate immune system, with a specific focus on the NLR (Nod-like receptor) family of proteins and inflammasomes in the biology of chronic diseases, including chronic kidney disease. The cellular and molecular biology of the renal epithelium, the role of inflammation and the immune system in renal injury and fibrosis are significant interests in the laboratory. Dr. Muruve has also led the establishment of a precision medicine and translational research program in kidney and glomerular diseases. Dr. Muruve is the Director of the Biobank for the Molecular Classification of Kidney Disease that provides a direct link to clinical patient samples as well as a clinicopathologic database to enable translational research in biomarkers, molecular epidemiology and genetics in kidney disease.
Clinical interests: Renal Physiology; Immune and Inflammatory Diseases of the Kidney; Genetic Kidney Diseases; Precision Medicine
Clinical Assistant Professor
Phone: 403-943-4881 | Fax: 403-212-1230
Dr. Burback’s clinical interests include the care of dementia patients. He enjoys teaching, and education has been a focus for him. He is currently a co-chair for Course 5, which is part of the training for second year medical students. He is the coordinator for electives and clinical rotations for undergraduate students and PGY1-PGY3 trainees. He enjoys music, and in his spare time he sings and plays the oboe in various groups at his church.
Vice Chair – Department of Medicine Education Office
Phone: 403-944-4490 | Fax: 403-944-4233
Dr. Fruetel joined the faculty of the University of Calgary as the Head of the Division of Geriatric Medicine and the Medical Leader for Specialized Geriatric Services and Medical Leader for Seniors. She served in those roles until 2016.
Aside from her interest in seniors’ health, she is also interested in medical education and has received awards including the Canadian Association of Medical Education certificate of Merit, the Schulich Award for Excellence in Education: Graduate./Postgraduate Education from the University of Western Ontario and the Department of Medicine Award of Excellence in Education, Cumming School of Medicine.
Clinical Associate Professor, Senior Medical Director – Seniors’ Health
Phone: 403-943-2719 | Fax: 403-943-2720
Dr. James Silvius moved to Calgary in 1991 as Medical Director for the Geriatrics program based at the Calgary General Hospital and Peter Lougheed Centre before moving to the Rockyview General Hospital in 2000. He developed an interest in administration early in his career and was the first Regional Medical Leader in the Calgary Health Region for Seniors Health, a role he defined and then filled until 2007. After a year as the Executive Medical Director, Southwest Community Portfolio, Calgary Health Region, he has held a number of roles with progressive responsibility. He is now a member of the AHS Senior Leadership Team as Medical Director, Provincial Seniors Health and Medical Director, Pharmacy Services. A Clinical Associate Professor, he maintains an active interest in dementia care, models of care, pharmaceutical care, and care delivery including Telehealth. He has been involved with formulary committees across the care continuum. He is the current chair of the AHS Drugs and Therapeutics Committee, former Chair of the Provincial Expert Committee for Drug Evaluation and Therapeutics (Alberta Health) from 2004 – 2015, and current Vice-Chair of the Canadian Drug Expert Committee (CADTH). His work in Telehealth both within Geriatrics and across the Department of Medicine led to him receiving the Department of Medicine’s Innovation Award in 2006, and he subsequently received the Department of Medicine’s Terry Groves Award for Clinical Excellence at the Rockyview Hospital in 2008.
Phone: 403-220-4578 | Fax: 403-283-6151
Dr. David Hogan was a member of the Faculty of Medicine, Dalhousie University from 1984 till 1990. While there he served as the Associate Dean for Undergraduate Medical Education. In 1990 he moved to the University of Calgary where he founded the Division of Geriatric Medicine, Department of Medicine. David is a Professor and holds the Brenda Strafford Foundation Chair in Geriatric Medicine at the University of Calgary (this was the first Chair of Geriatric Medicine in Canada and he has been its first and to date only holder). He has served as Chair of the RCPSC Specialty Committee in Geriatric Medicine, Chair of the RCPSC Examination Board in Geriatric Medicine, President of the Canadian Geriatrics Society, and Editor of the Canadian Geriatrics Journal. David has authored over 500 publications (approximately 250 peer-reviewed).
Zone Clinical Section Chief – Respiratory Medicine, Vice-Chair – Health Analytics & Safety, Professor
Phone: 403-220-8810 | Fax: 403-210-7944
Phone: 403-220-8722 | Fax: 403-283-6151
Clinical interests: Sleep Apnea, General Respiratory Medicine
Research interests: Health System Improvement, Safety Management
Phone: 403-210-7065 | Fax: 403-210-9286
Dr Brenda Hemmelgarn is a clinician scientist with sub-specialty training in Nephrology from the University of Calgary and a PhD in epidemiology from McGill University. She is Professor and Head of the Department of Community Health Sciences where she undertakes her academic activities, and maintains a clinical practice in nephrology through the Department of Medicine. Her research interests are in the study of chronic medical conditions including chronic kidney disease, diabetes, hypertension and cardiovascular disease, as well as knowledge translation strategies to improve care provided to this patient population. She is the recipient of the Roy and Vi Baay Chair in Kidney Research, has over 390 peer-reviewed publications, and has received numerous awards and recognitions including Fellowship in the Canadian Academy of Health Sciences.
Phone: 403-944-5916 | Fax: 403-944-5803
Clinical Interests: Transplant Nephrology, Quality Assurance/Quality Improvement
Phone: 403-220-2550 | Fax: 403-210-6660
Email: Sajjad Surani
Clinical Interests: General Nephrology, Dialysis Therapies
Research Interests: Dialysis Therapies, Chronic Kidney Disease, Vascular Access, Peritoneal Dialysis Access, Quality Improvement
Phone: 403-944-2744 | Fax: 403-944-2876
Dr. Kelvin Leung completed medical school at the University of Alberta, Edmonton, Canada, obtained his specialty training in Internal Medicine at the University of Manitoba, Winnipeg, Canada, and his subspecialty Adult Nephrology at the University of Calgary, Calgary, Canada. Dr, Leung is the medical co-director of vascular access.
Clinical and Research Interest: Hemodialysis, Vascular Access, Volume Control
Phone: 403-944-2667 | Fax: 403-944-5803
Clinical and Research Interests: General Nephrology, Chronic Kidney Disease, Dialysis and Pregnancy in Kidney Disease
Academic Interests: Medical Education
Phone: 403-220-6499 | Fax: 403-210-6660
Email: Karla Belcourt
Clinical and Research Interests: Chronic Kidney Disease
Dr Manns’ research interests include examining implications of patient-borne costs on care and outcomes in chronic disease, examining cost effectiveness of strategies and health care policies for managing patients with chronic disease, and assessing the adequacy of care for Albertans with diabetes. He has experience in pharmaceutical priority setting, having served on provincial and national committees for drug evaluation, including a term as Chair of the Canadian Expert Drug Advisory Committee from 2006-2008.
Phone: 403-220-2465 | Fax: 403-210-6660
Email: Kathleen Fenrick
Dr. Pietro Ravani is a Professor of Medicine with the department of Medicine and the department of Community Health Sciences at the University of Calgary. He is a member of the O’Brien Institute of Public Health and of the Libin Cardiovascular institute of Alberta, and practicing nephrologist within the Southern Alberta Renal Program – Kidney Health Strategic Clinical Network.
Dr. Ravani received his medical training at the University of Parma, Italy, and completed a Master’s of Science in Biostatistics at the University of Pavia, Italy, followed by a PhD in Clinical Epidemiology at Memorial University in Newfoundland. Dr. Ravani worked as a practicing physician in Italy until 2008, when he moved to Calgary to start his academic career.
Clinical interest/expertise: Clinical nephrology, chronic kidney disease, dialysis therapies.
Research interest/expertise: Research methodology: statistical methods in outcomes research and design of clinical trials and longitudinal studies, systematic reviews and meta-analyses; Research topics: hemodialysis access, dialysis modalities and home care, idiopathic nephrotic syndrome, transition between disease states or health care programs.
Dr. Ravani has conducted numerous studies in chronic kidney disease patients including randomized controlled trials, and has received operating grants from Canadian Institutes of Health Research (CIHR).
Phone: 403-944-1169 | Fax: 403-270-0055
Clinical Interests: Hypertension, Chronic Kidney Disease, Glomerulonephritis
Phone: 403-220-3880 | Fax: 403-283-1267
Clinical Interests: Transplant Nephrology
Associate Vice President – Research – University of Calgary, Professor
Dr. Tonelli is a graduate of the University of Western Ontario’s Faculty of Medicine (1995), and completed his postdoctoral training at the University of Western Ontario (1998), Dalhousie University (2002) and the Harvard School of Public Health (2002). He spent 12 years with the University of Alberta’s Department of Medicine, and joined the University of Calgary Cumming School of Medicine in 2014, taking on the role of Senior Associate Dean (Health Research).
Dr. Tonelli’s research focus is improving the care of people with chronic kidney disease and other noncommunicable diseases. He has partnered with regional, provincial and national decision-making bodies to inform clinical practice and impact health policy in this area. He completed a volunteership at the World Health Organization in 2013-2014, focusing on treatment of noncommunicable diseases following natural disasters and civil conflict. During this time he also completed an MSc in Health Policy from Imperial College London.
Dr. Tonelli is a co-lead for the Alberta-based Interdisciplinary Chronic Disease Collaboration. He is chair emeritus of the Canadian Task Force on Preventive Health Care and a past President of the Canadian Society of Nephrology. He leads the International Society of Nephrology’s global research portfolio and is a member of the Governing Council of the Canadian Institutes of Health Research. He established and is the inaugural Director of the Pan American Health Organization/World Health Organization Collaborating Centre for the Prevention and Control of Chronic Kidney Disease.
Dr. Tonelli was the recipient of the 2013 United States National Kidney Foundation Medal for Distinguished Service and the Kidney Foundation of Canada’s 2013 Medal for Research Excellence for changing nephrology practice in Canada and beyond. Along with the two other team co-leads, he received a Top Canadian Achievements in Health Research Award from the CIHR-CMAJ in 2013 for his work with the Interdisciplinary Chronic Disease Collaboration. He was elected a fellow of the Canadian Academy of Health Sciences in 2012 and a member of the American Society for Clinical Investigation in 2014. He was named a “Highly Cited” researcher every year since 2015 by Thomson-Reuters Web of Science, corresponding to a rank in the top 0.1% by citations of all researchers worldwide over the preceding decade.
Zone Clinical and Academic Department Head, Professor
Dr. Jayna Holroyd-Leduc is the Geriatric Section Head and an Associate Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary. She received her medical degree and then completed residency training in Internal Medicine and Geriatrics at the University of Toronto. She completed a research fellowship in Geriatrics and Quality Improvement as a VA Quality Scholar at the University of California, San Francisco, USA. Her research interests include knowledge synthesis and translation focused on improving care provided to older adults. She is also very active in leading and promoting quality improvement initiatives within the Calgary zone and across Alberta, targeted towards frail seniors and their caregivers. She is the KT Chair of the Canadian Frailty Network NCE, an Associate Editor for the Canadian Medical Association Journal, and the previous Scientific Director of the Alberta Health Services Seniors Health Strategic Clinical Network.
Phone: 403-943-8832 | Fax: 403-943-8592
Academic interests: Undergraduate Education
Program Director – Geriatric Medicine Training Program, Clinical Assistant Professor
Phone: 403-944-4490 | Fax: 403-944-4233
Paula moved to Calgary in 2010 to work in the Division of Geriatric Medicine, based at Rockyview General Hospital. She is a Clinical Associate Professor in the Department of Medicine. She is one of the Masterteachers at the University Of Calgary Cumming School Of Medicine and is Course Chair for one of the undergraduate courses in the MD program. She became Program Director of the newly activated Geriatric Medicine residency training program in 2012.
Phone: 403-943-3453 | Fax: 403-212-1230
Inpatient Geriatric Medicine, Sleep, and Mobility.
Phone: 403-943-4881 | Fax: 403-956-3838
Phone: 403-956-2480 | Fax: 403-956-3838
Dr. Schmaltz completed her medical degree and internal medicine residency at McGill University, followed by a clinical & research fellowship in Geriatric Medicine and Gerontology at Johns Hopkins School of Medicine. Currently, she provides inpatient and outpatient geriatric medicine consults at South Health Campus. Clinically, she particularly enjoys the challenges of dementia care, particularly reactive behaviours, as well as collaborating with our One Line Referral team. Dr. Schmaltz is the Rural Outreach lead for Senior’s Health in Calgary, and has clinics in Claresholm and Vulcan.
She is the Section Lead for Rural Outreach and Continuing Professional Development, both tools she believes are valuable in supporting optimal care for complex older adults, particularly in rural areas. Dr. Schmaltz helped develop and continues to chair the Annual Geriatrics Update: Clinical Pearls offered through the University of Calgary Department of CME and CPD. She is also active in the CPD committee of the Canadian Geriatrics Society. In her spare time, Dr. Schmaltz most enjoys spending time with her family, especially her two young children.
Dr Schmaltz welcomes residents with an interest in educational leadership the opportunity to be involved in CME and CPD scholarship at a local and national level.
Phone: 403-220-5903 | Fax: 403-210-7367
Phone: 403-955-8930 | Fax: 403-955-8196
Clinical Interests: Early Inflammatory Arthritis, Rheumatoid Arthritis, SLE
Research interests: Quality Indicators, Epidemiology, Health Services
Phone: 403-220-3880 | Fax: 403-210-9717
Clinical interests: Rheumatoid Arthritis, Indigenous Health
Research interests: Epidemiology and Health Services Research
Phone: 403-220-3533 | Fax: 403-220-8737
Research interests: Biomarker (Autoantibodies) Discovery, Diagnostic Assay Development
Quality/Safety Interests: College of American Pathologists QA/QC Program
Phone: 403-955-8927 | Fax: 403-955-8196
Clinical Interests: Early Inflammatory Arthritis
Research interests: Early Inflammatory Arthritis, Patient Preferences, Clinical Practice Guidelines, Comparative Effectiveness Research
Phone: 403-221-4465 | Fax: 403-221-4419
Phone: 403-220-2808 | Fax: 403-210-7367
Clinical Interests: General Rheumatology
Phone: 403-955-8717 | Fax: 403-955-8196
Clinical interests: Spondyloarthropathy, First Nations Outreach Clinics
Research interests: Models of care for arthritis, Outcome measures for patients with arthritis
Phone: 403-953-8303 | Fax: 403-955-8196
Clinical interests: Ultrasound Program, MSK physical examination, Medical education
Clinical interests: Uveitis, Spondyloarthritis
Research interests: Spondyloarthropathy / SPARCC Database, Uveitis Database
Phone: 403-266-1246 | Fax: 403-233-9278
General Hematology including malignant and benign disorders.
Zone Clinical Section Chief – Hematology, Clinical Associate Professor
Phone: 403-944-5246 | Fax: 403-944-1647
Phone: 403-521-3706 | Fax: 403-521-3743
Clinical Interests: Allogeneic Hematopoietic cell transplantation
Research Interests: Alternative donor sources and outcomes in HCT
Multiple Myeloma, Lymphoma, Autologous Stem Cell Transplant
Phone: 403-944-8047 | Fax: 403-270-7891
Clinical Interests: General Hematology, and Hematopoietic Cell Transplantation
Research Interests: Acute Leukemias, Myelodysplasia, Myeloproliferative Disorders, and Aplastic Anemia
Phone: 403-944-5948 | Fax: 403-944-8352
Phone: 403-944-1564 | Fax: 403-944-2102
Interested in Primary Immune Deficiencies and Bone Marrow Failure syndromes
Phone: 403-944-4451 | Fax: 403-944-1647
Myeloproliferative Disorders, and Medical Education
Clinical interests: Lymphoproliferative Disorders – Lymphoma and Chronic Lymphocytic Leukemia
Research interests: Clinical Trials, Genetic Predisposition to Familial Hematological Disorders (MDS/AML), Genetic Predictors of Rare Lymphoma Entities
Phone: 403-944-4753 | Fax: 403-944-2102
Phone: 403-944-3265 | Fax: 403-944-2102
Rare Blood and Bleeding Disorders
AML, ALL, MDS/MPN’s, CML, Allogeneic Transplant
Phone: 403-944-1993 | Fax: 403-270-7891
Malignant Hematology, with a focus on the management of patients with Lymphoma and CLL, and the role of stem cell transplantation for these diseases.
Phone: 403-210-3935 | Fax: 403-210-8176
Immunology of Hematopoietic Cells
Thrombosis with a focus on safety and efficacy of direct oral anticoagulant therapy in special population and cancer associated thrombosis.
Myeloma, Transfusion Medicine, Supportive Care, Patient Reported Outcomes
Phone: 403-956-2468 | Fax: 403-956-3836
Clinical Adult Hematology
Program Director – Adult Respirology Training Program, Clinical Associate Professor
Phone: 403-944-2325 | Fax: 403-252-6471
Phone: 403-943-3283 | Fax: 403-252-6471
Clinical Interests: General Respiratory Medicine
Phone: 403-956-2435 | Fax: 403-953-2404
Clinical Interests: Interstitial lung diseases (ILD), Hereditary Hemorrhagic Telangectasia (HHT), General Pulmonary Medicine
Research Interests: Diagnosis and natural history of ILD, Health related quality of life in patients with ILD, patient-reported outcomes in ILD
Phone: 403-220-8722 | Fax: 403-283-6151
Phone: 403-220-8742 | Fax: 403-210-7944
Clinical interests: All aspects of Respiratory Medicine
Research interests: Airway Disease, Chronic Cough, Respiratory Infections, Mycobacterial Disease
Phone: 403-943-4971 | Fax: 403-948-4848
Clinical Interests: Tuberculosis, Non-Tuberculous Mycobacterial Lung Disease, Obstructive Lung Disease, Asthma
Research Interests: Multi-Drug Resistant Tuberculosis, Extra-Pulmonary Tuberculosis, Screening and Treatment of Latent Tuberculosis Infection
Phone: 403-943-8864 | Fax: 403-943-8666
Phone: 403-943-8864 | Fax: 403-943-8666
Clinical interests: General Respirology, Sleep Medicine
Research interests: Medical Education, Cognitive Load Theory, Medical Simulation
Medical Director – FMC Sleep Centre, Clinical Professor
Phone: 403-210-8694 | Fax: 403-283-6151
Clinical interests: Sleep Medicine
Research interests: Pathophysiology of Sleep Apnea, Cardiovascular complication of Sleep Apnea, Sleep Apnea and Renal Function
Phone: 403-944-3224 | Fax: 403-943-4017
Clinical interests: Lung Transplant, Pulmonary Hypertension
Research interests: Lung Transplant, Pulmonary Hypertension
Phone: 403-210-3866 | Fax: 403-944-1577
Clinical Interests: Interventional Pulmonary Medicine, Bronchoscopy, Procedural Training/Medical Education, Procedural Data Registries, Pleural Ultrasound, Electromagnetic Navigation Bronchoscopy
Research Interests: Interventional Pulmonary Medicine, Procedural Training, Procedural Data Registries
Phone: 403-220-8857 | Fax: 403-210-7944
Phone: 403-943-4779 | Fax: 403-943-4017
Clinical interests: Pulmonary Vascular Diseases
Research interests: Clinical trials in Pulmonary Arterial Hypertension and other pulmonary diseases
Phone: 403-943-5425 | Fax: 403-943-4017
Clinical Interests: Tuberculosis, Nontuberculous Mycobacterial Infections, Non-CF Bronchiectasis
Research Interests: Tuberculosis, Nontuberculous Mycobacterial Infections, Non-CF Bronchiectasis
Phone: 403-956-2435 | Fax: 403-956-2991
Clinical interests: Interstitial Lung Disease
Research interests: Interstitial Lung Disease, Environmental and Occupational Health, Clinical Epidemiology, Public Health
Senior Associate Dean – Faculty Affairs, Professor
Phone: 403-220-4245 | Fax: 403-210-7944
Phone: 403-210-8945 | Fax: 403-210-7944
Clinical and Research interests: Sleep, Neuromuscular, Chronic Ventilation
Quality & Safety Interests: Education – Quality and Safety Management, Teamwork, Systems Analysis
Phone: 403-956-2435 | Fax: 403-956-2848
Phone: 403-956-2800 | Fax: 403-956-2848
Clinical interests: Advanced Lung Disease and Palliative Care
Research interests: Dyspnea management, Improving care for patients with Advanced Lung Disease
Phone: 403-220-6882 | Fax: 403-283-6151
Clinical interests: Thoracic Oncology, Bronchoscopy, Pleural Disease, Benign and Malignant Airway Obstruction
Research interests: Lung Cancer screening, Bronchoscopic procedures
Phone: 403-220-8774 | Fax: 403-210-7944
Phone: 403-210-8945 | Fax: 403-210-7944
Clinical Interests: Infectious and Immunologic Lung Disease
Research Interests: Microbial Host Defense
Phone: 403-210-3904 | Fax: 403-283-6151
Clinical Interests: Sleep Medicine, Sleep-Disordered Breathing
Research Interests: Patient Flow, Access, sleep Medicine, Process Improvement
Clinical interests: Chronic Ventilation, Respiratory Care of Neuromuscular, and Chest Wall Patients
Research interests: Chronic Ventilation, Respiratory Care of Neuromuscular, and Chest Wall Patients
Phone: 403-943-4833 | Fax: 403-943-4017
Clinical and Research interests: Lung Transplantation, Pulmonary Hypertension, General Pulmonary
Phone: 403-210-3866 | Fax: 403-944-1577
Clinical and Research interests: Interventional Pulmonary Medicine, Thoracic Oncology
Clinical interests: General Respirology, Sleep Medicine, Critical Care and Pulmonary Ultrasound, COPD
Research interests: Administrative Data, Predictive Analytics, Health Outcomes Assessment
Medical Director – Calgary COPD and Asthma Program, Clinical Assistant Professor
Phone: 403-220-4135 | Fax: 403-210-9149
Clinical interests: Primary focus on Airways Diseases (COPD and Asthma)
Research interests: Severe COPD and difficult to control Asthma, Impact/efficacy of Respiratory Education
Clinical interests: Pulmonary Hypertension, Thromboembolic Disease, Interstitial Lung Disease
Research interests: Hemodynamics and outcomes in Pulmonary Vascular Disease, Exercise Physiology in Pulmonary Hypertension, Wave Intensity Analysis, Risk Stratification in Pulmonary Hypertension.
Phone: 403-220-6617 | Fax: 403-283-6151
Medical Director – Diabetes in Pregnancy, Clinical Associate Professor
Phone: 403-955-8358 | Fax: 403-955-8249
She has special interests in Endocrine Disorders in Pregnancy and Monogenic Diabetes. Her clinical expertise includes many aspects of endocrinology including diabetes and thyroid disease in pregnancy, diabetes, thyroid, and pituitary disease and reproductive endocrinology. Her research is focused on Diabetes in Pregnancy and Thyroid Disease in Pregnancy. She is a clinical investigator in a number of local, provincial, national and international trials with research funding from CIHR, AHRQ and JDRF. Dr. Donovan is also very involved in teaching undergraduate medical students, postgraduate resident training and continuing medical education.
She has a longstanding special interest in Diabetes and in Pregnancy. She in on the 2018 Canadian Diabetes Association Diabetes in Pregnancy guidelines committee. She is current past Chair of the Canadian Diabetes in Pregnancy Special Interest group (CanDIPS). She was the clinical investigator on the AHRQ contract for the Systematic Review to Inform National Institute of Health (NIH) consensus meetings, March 2013, about the optimal approach for GDM screening and Diagnosis funded by the U.S. Preventive Services Task Force (USPSTF) and the Office of Medical Applications of Research (OMAR) in the United States.
Phone: 403-221-4476 | Fax: 403-221-4418
Phone: 403-956-2393 | Fax: 403-956-3835
Clinical areas of interest include all aspects of endocrinology, including reproductive endocrinology, pituitary, adrenal, thyroid, diabetes and diabetes in pregnancy. She holds Master of Science degrees in Medical Genetics from the University of Alberta, and in Health Information Sciences from the University of Victoria. In 2013, she joined the Department of Medicine at the University of Calgary as a Clinical Assistant Professor, and Alberta Health Services as a Clinical Informatics Physician. Dr. Helmle’s research interest in the interplay between health information technologies, quality improvement and knowledge translation strategies, and its application to inpatient diabetes management, began through the Basal Bolus Insulin Therapy (BBIT) project, and has continued to grow since its inception during her residency training in Calgary, and has earned national and international recognition. With the support of the Alberta Health Services, Diabetes Obesity and Nutrition Strategic Clinical Network, this research is now being implemented provincially in Alberta. In her role as a Clinical Informatics Physician, she provides clinical support to acute and ambulatory Sunrise Clinical Manager order set, documentation, and clinical decision support projects. Finally, Dr. Helmle has an ongoing interest in medical education at the Undergraduate and Postgraduate levels.
Dr. Kinnear’s clinical expertise includes thyroid disease, diabetes, menstrual disorders, pituitary and adrenal disease. She has a clinical special interest in thyroid cancer, thyroid nodules and thyroid ultrasound and biopsies. She provides thyroid cancer care in clinics at both the Tom Baker Cancer Centre and her clinical practice at the Associate Clinic, and is a member of the Thyroid Cancer Triage Group within the Division of Endocrinology.
Dr. Kinnear is also spends a significant amount of time with medical education, both at the undergraduate and post-graduate level. She serves as the Clinical Clerkship Supervisor for medical students on Endocrinology rotation, and as a member of the Resident Training Committee for the Endocrinology fellowship program.
Phone: 403-955-8327 | Fax: 403-955-8248
Dr. Kline is now the Medical Director of the Hanley Osteoporosis Clinic. His clinical and research interests include osteoporosis and endocrine hypertension. Outside of Calgary, he has a particular interest in training junior physicians working in the developing world.
Dr. Leung’s clinical work is in general endocrinology and includes thyroid, pituitary, adrenal, and lipid disorders. He has a special interest in endocrine hypertension and hereditary endocrine tumors. He is also a population health researcher with academic interests in hypertension and cardiometabolic disorders. His research agenda is to study the care of individuals with hypertension, to identify existing care gaps, and to examine potential solutions that may improve care delivery.
Her clinical expertise includes many aspects of endocrinology including diabetes, diabetes in pregnancy, thyroid, pituitary and adrenal disease. Dr. McKeen is also heavily involved in both undergraduate medical school and postgraduate resident training. She is also a contributor to Continuous Medical Education programs, particularly for allied healthcare professionals in the area of diabetes.
With her interest in diabetes and clear leadership skills, in 2009 she was appointed as the Medical Director of the Diabetes, Hypertension and Cholesterol Center in Calgary. Working alongside a strong administrative team, the program has expanded to one of the largest in Western Canada and continues to offer patients excellent and timely care for their diabetes and associated conditions.
Dr. McKeen became a Core Committee member of the AHS Diabetes Obesity Nutrition Strategic Clinical Network (DON SCN) in 2011, participating in the development of the Alberta Health Insulin Pump Therapy Program and is the Medical Lead of the Provincial Inpatient Diabetes Management Initiative.
Phone: 403-955-8342 | Fax: 403-955-8248
Dr. Parkins is the Program Director for the Adult Endocrinology & Metabolism Specialty Training Program at the University Of Calgary. Her clinical interests Include Endocrine Oncology, Diabetes, Diabetes in Pregnancy and Cystic Fibrosis-Related Endocrinopathy.
Ralf Paschke served as Division Head of Endocrinology at the University of Calgary, Zone Head of Endocrinology in Calgary from July 2015 to May 2019. In November 2015, he was elected as the chair of the provincial endocrine tumour team in Alberta.
Ralf Paschke spent 4 years as a Heisenberg Professor in a molecular laboratory in the Institute of Interdisciplinary Research at the Universite Libre in Brussels, Belgium working on the molecular etiology of hot thyroid nodules and the mechanism of activation of the TSHR. He was appointed Professor of Internal Medicine and Endocrinology at the University of Leipzig in 1995. His major research interests include thyroid cancer, thyroid nodules, thyroid nodule molecular fine needle cytology (FNAC) diagnostics, the TSH-receptor and diseases caused by TSH-receptor mutations. He trained in Pathology, Internal Medicine and Endocrinology in the university hospitals of Frankfurt, Mannheim and Muenster. He served for 9 years as Director of the Medical Department III at Leipzig University with the sections Endocrinology, Diabetes and Nephrology. He was also the coordinator for endocrine research and deputy chairman of the Interdisciplinary Centre for Clinical Research at the University of Leipzig, Germany. He is the author of more than 350 original journal articles, co-author of several thyroid guidelines and serves on the editorial boards of several journals including Thyroid, European Thyroid Journal and repeatedly the JCEM.
As 85 % of thyroid nodule ultrasound reports in Calgary did not allow to stratify the respective thyroid nodule for its malignancy risk (Symonds et al, Endocrine, 2018) he implemented a stratified thyroid nodule ultrasound malignancy risk assessment in Calgary 9/2017 together with Paula Seal (EFW Radiology) and Chris Symonds (Endocrinology). The malignancy risks for Bethesda thyroid nodule FNAC categories in Calgary were presented at the ATA meeting October 2017 by Sana Ghaznavi. A lobectomy proposal for patients with thyroid nodules or thyroid cancer was implemented 4/2017 and revised 10/2017 with the thyroid surgeons in Calgary. It led to 20% lobectomies for thyroid cancer since 4/2017. Together with the Calgary Primary Care Networks (PCNs) Ralf Paschke implemented a thyroid nodule pathway 3/2018. The prospective evaluation of molecular FNA diagnostics for indeterminate thyroid nodules with the Calgary ThyroSPEC™ panel covering 117 point mutations and 23 rearrangements invented by him and Markus Eszlinger led to its implementation by Alberta Public Laboratories and Alberta Health Services 10/2019. ThyroSPEC™ is a reimbursed routine molecular test for indeterminate thyroid nodule FNA cytologies to replace 600 diagnostic lobectomies per year in Alberta and potentially 3500 diagnostic lobectomies in Canada.
Ralf Paschke chaired the European Thyroid Association guideline task forces generating the guideline for the management of non-autoimmune hyperthyroidism and the guideline for molecular diagnostics of indeterminate thyroid nodule FNA cytologies. He was involved as a coauthor in three updates of the thyroid nodule guideline by the American Association of Clinical Endocrinologists, Assoziazione Medici Endocrinolgi, and European Thyroid Association and the European Thyroid Association guideline task force for cervical ultrasound scan and ultrasound guided techniques in the postoperative management of patients with thyroid cancer.
Recently he led the discovery of additional EZH1 mutations in hot nodules with TSHR mutations (Calebiro et al., JCI, 2016). Joining forces with Jukka Kero and with the very experienced transgenic facility in Turku led by Matti Poutanen, he recently published a mouse model of non-autoimmune hyperthyroidism with the first description of papillary thyroid cancers most likely induced by increased TSHR signaling (Jaeschke et al., Thyroid, 2018).
During the years 2015 – 2019 Ralf Paschke saw 40% of the patients with a new diagnosis of thyroid cancer in Calgary. Based on his previous experience as a local PI for the Lenvatinib and Sorafenib phase 3 studies and the Astra study investigating Selumetinib for the adjuvant radioiodine treatment of patients with high recurrence risk thyroid cancers he continued to focus his clinical work on the treatment of radioiodine resistant metastatic thyroid cancer. He is the local PI for the early access and special access programs for RET and NTRK inhibitors and 2 further current thyroid cancer tyrosine kinase inhibitor studies in Calgary. After the successful resensitization treatment of the first patient in Calgary, five further patients have recently been treated for RAI resensitization in Calgary. With the help of Markus Eszlinger and Sorana Morrissy whole exome sequencing (WES) analysis with mutational phylogenetic tree analysis of their primary tumours was used to predict success or failure of this approach and to identify targets for the off-label use of other tyrosine kinase inhibitors. In addition to the known driver mutations in BRAF and RAS, previously described EIF1AX and AKT1 mutations and also new alterations in oncogenic pathways, for example in the cell cycle pathway (E2F1 and CDK6 mutations) which could be targeted for example by mTOR inhibitors (EIF1AX, AKT1) or CDK inhibitors like Palbociclib (CDK6) were identified. These results will allow to better stratify for newer and individually targeted drugs in case of radioiodine resensitization failure with Selumetinib, Vemurafenib, Tramatenib, or Dabrafenib.
Associate Professor, Zone Clinical Section Chief – Endocrinology
Phone: 403-220-3319 | Fax: 403-955-8248
Dr. Rabi joined the Department of Medicine at the University of Calgary as a Clinical Scholar in 2003 and began graduate studies in clinical epidemiology within the Department of Community Health Sciences. She is now an Associate Professor in the Department of Medicine and has cross appointments with the Departments of Community Health and Cardiac Sciences. She is an Alberta Innovates- Health Solutions (AIHS) Population Health Investigator and has funding from the Canadian Institutes of Health Research, Natural Science and Engineering Research Council and the Heart and Stroke Foundation.
As an academic endocrinologist, Dr. Rabi is situated at the Cumming School of Medicine has dedicated time for original research. She has over 70 peer-reviewed publications and her research program is focused on the cardiovascular complications of diabetes. She has CIHR funding to investigate novel approaches to engaging patients in the self-management of chronic diseases like diabetes and hypertension. Dr. Rabi has provided supervision to many graduate students and provides course teaching in Systematic Reviews and Meta-analyses within the department of Community Health Sciences and does several diabetes lectures for the Cumming School of Medicine Endocrine and Renal course.
With a strong research background, Dr. Rabi is a nationally recognized for her contributions to clinical practice guidelines in hypertension and diabetes. Dr. Rabi is the Chair of the Hypertension Canada (formerly Canadian Hypertension Education Program) Guidelines Committee and she a member of the executive committee for the 2018 Canadian Diabetes Association Clinical Practice Guidelines.
Clinical interests of Dr. Rabi include diabetes, cardiovascular risk reduction and diabetes in pregnancy.
Clinical interests: Thyroid, Pituitary, Adrenal Disorders, Endocrine Oncology
Phone: 403-955-8327 | Fax: 403-955-8249
Dr. Ron Sigal is Professor of Medicine, Kinesiology, Cardiac Sciences and Community Health Sciences at the Cumming School of Medicine, University of Calgary. He is active in clinical medicine, teaching and research.
He has held a Health Senior Scholar award from Alberta Innovates-Health Solutions, and previously a Canadian Institutes of Health Research (CIHR) New Investigator Award. Dr. Sigal’s current research focuses on clinical trials related to physical activity, diabetes and cardiovascular disease.
Dr. Sigal is a practicing endocrinologist, who has cared for people with diabetes for more than 20 years. He has volunteered for the Canadian Diabetes Association (CDA) in several capacities since 1997. He is currently co-chair of the CDA Professional Section Executive and a member of the CDA Board of Directors. He served on the CDA Expert Committee that developed the CDA Clinical Practice Guidelines for 2003, 2008, 2013 and 2018, and also on the Dissemination and Implementation Committee for these guidelines. He has been the lead author of the guidelines on Physical Activity/Exercise for the Canadian Diabetes Association (2003, 2008, 2013, 2018) and the American Diabetes Association (2006).
Phone: 403-956-2393 | Fax: 403-956-2848
Clinical interests: Interventional Pulmonary Medicine
Research interests: Endobronchial removal of Aspergilloma, Genetics behind Idiopathic Tracheal Stenosis, Chest Ultrasound, Pathologic changes with Thermal Bronchoscoplasty in Asthma
Clinical interests: Mechanisms and Treatment of Sleep Apnea
Research interests: Pathophysiology of the control of breathing and selection of patients with Sleep Apnea for optimal therapy
My research interests over time have focused on the biosynthesis and actions of peptide hormones (oxytocin, vasopressin, insulin, epidermal growth factor) and on the molecular pharmacology and pathophysiology of receptor-mediated signaling by growth factors and G-protein coupled receptors (GPCRs). This focus seeks to understand rapid events occurring in tissues like smooth muscle, responsible for the regulation of blood vessel and intestinal motility. Recent work is studying the hormone-like signaling properties of proteinases that act in part via the ‘proteinase-activated receptor (PAR)’ family of GPCRs. The PARs regulate diverse pathophysiological processes ranging from vascular angiogenesis and contractility to arthritic and intestinal inflammation and pain. As one major focus, we are studying the activation of these receptors (PARs 1, 2 and 4) by thrombin, trypsin and other serine proteinases, like the tumour-derived tissue kallikrein family. We are particularly interested in the signalling pathways for the PARs that are in common with those for growth factor receptors, resulting in the activation of cellular tyrosine kinase pathways in the vasculature and other target tissues. A major direction related to signaling by proteinases seeks to identify, with the use of activity-based covalent proteinase labeling probes and proteomic analysis, those serine proteinases responsible for regulating cell and tissue function via the PARs in the settings of health and disease.
Clinical interests: General Endocrinology, Diabetes, Diabetes in Pregnancy, Transgender Care, Diabetes care of Underserved and Vulnerable Populations.
Phone: 403-943-2502 | Fax: 403-943-4017
Clinical Interests: General Respiratory Medicine, COPD, Asthma
Research Interests: Bronchoscopy Simulation
Phone: 403-210-6614 | Fax: 403-210-9149
Clinical Interests: Sleep Medcine
Phone: 403-943-3475 | Fax: 403-943-8666
Clinical Interests: Cardiopulmonary Exercise Testing, Pulmonary Rehabilitation
Research Interests: Cardiopulmonary Exercise Testing, Pulmonary Rehabilitation
Autologous and Allogeneic Stem Cell Transplant
Clinical interests: Lung Transplantation, Pulmonary Hypertension
Research interests: Lung Transplantation, Pulmonary Hypertension, Frailty, and Quality of Life
Phone: 403-943-4308 | Fax: 403-291-1491
Clinical interests: Critical Care Medicine, Pulmonary Hypertension
Clinical interests: Occupational Pulmonary Medicine, Occupational Asthma
Research Interests: Occupational Asthma, Work-Exacerbated Asthma
Phone: 403-220-4341 | Fax: 403-283-1267
Clinical interests: Critical Care, ARDS, Sepsis, TBI
Research interests: Sepsis, ARDS, TBI, Metabolomics
Phone: 403-830-6781 | Fax: 403-457-5860
Phone: 403-943-8470 | Fax: 403-943-8666
Clinical interests: Osteoporosis, Rheumatic Disease
Research interests: Fracture Liaison Service
Clinical Interests: Diabetes, Adrenal Disorders, Thyroid Disease, Pituitary Disorders, and Metabolic Bone Disease.
Phone: 403-221-4479 | Fax: 403-221-4403
Clinical interests: Clinical Immunology and Allergy
Phone: 403-956-2468 | Fax: 403-956-3836
Phone: 403-220-5951 ext 1 | Fax: 403-270-2772
Phone: 403-220-7082 | Fax: 403-210-7882
Clinical Assistant Professor, Zone Clinical Section Chief – Infectious Diseases
Phone: 403-220-5951 ext 1 | Fax: 403-270-2772
Clinical Assistant Professor, Zone Clinical Section Chief – Rheumatology
Phone: 403-220-2808 | Fax: 403-955-8196
Zone Clinical and Academic Deputy Department Head, Zone Clinical Section Chief – General Internal Medicine, Clinical Professor
Phone: 403-943-8864 | Fax: 403-943—8666
Clinical interests: Asthma, COPD, Chronic Eosinophilic Airways Disease, Autoimmune Pulmonary Diseases, Young Adults with Asthma (YAWA), Sarcoidosis, Pulmonary Thromboembolic Disease, Airways Disease in Pregnancy
Research interests: Asthma, COPD, Eosinophilic Pulmonary Diseases, Transitional Clinics, Atopic and Allergic Disease
Quality/Safety interests: Education – Quality and Safety Management, Teamwork, Systems Analysis
Dr. Patrick Mitchell joined the University of Calgary’s respiratory team in July 2016. He trained as a specialist in Respiratory and Internal medicine in Ireland. He undertook a two year clinical and research fellowship at McMaster University under Prof Paul O’Byrne. This encompassed translational research in airway inflammation and servicing both general respiratory and airway inflammation clinics. Dr. Patrick Mitchell also completed a two-year Medical Doctorate thesis on the role of IL-33 in allergic asthma. He has been appointed director of the Asthma and COPD program at the Rockyview Hospital. He has authored numerous peer reviewed research manuscripts and co-authored a book chapter on asthma. His clinic interests are asthma, COPD, chronic eosinophilic airways disease, autoimmune pulmonary diseases, Sarcoidosis, Pulmonary Thromboembolic disease and airways disease in pregnancy.
Phone: 403-944-5530 | Fax: 403-944-2876
Phone: 403-955-8659 | Fax: 403-955-8200
Dermatology Post-Graduate Program Administrator, Clinical Associate Professor
Phone: 403-955-8696 | Fax: 403-955-8200
Phone: 403-944-4904 | Fax: 403-270-7891
Phone: 403-943-5681 | Fax: 403-943-4017
Phone: 403-210-6614 | Fax: 403-210-9149
Phone: 403-943-2501 | Fax: 403-943-4017
Phone: 403-220-3719 | Fax: 403-592-5090
Phone: 403-220-2293 | Fax: 403-592-5090
Phone: 403-220-8389 | Fax: 403-592-5050
Phone: 403-592-5089 | Fax: 403-944-3838
Phone: 403-592-5049 | Fax: 403-944-6559
Phone: 403-592-5015 | Fax: 403-592-5015
Phone: 403-220-8892 | Fax: 403-283-6151
Adjunct Assistant Professor
Phone: 403-944-2477 | Fax: 403-944-6548
Phone: 403-210-9317 | Fax: 403-210-3818
Phone: 403-944-5164 | Fax: 403-944-5803
Email: Jenn Vo
Phone: 403-944-2510 | Fax: 403-944-3199
Email: Kim Puschner
Phone: 403-284-4222 | Fax: 403-284-5272
Phone: 403-944-1564 | Fax: 403-28944-2102
Phone: 403-255-1633 | Fax: 403-259-5245
Phone: 403-944-2038 | Fax: 403-944-1934
Phone: 403-943-5708 | Fax: 403-943-4471
Phone: 403-220-8382 | Fax: 403-210-9084
Phone: 403-955-8907 | Fax: 403-955-8196
Phone: 403-956-2401 | Fax: 403-956-2995
Phone: 403-943-8896 | Fax: 403-943-8535
Email: Christine Finch
Phone: 403-943-3453| Fax: 403-212-1230
Phone: 403-944-3939 | Fax: 403-270-0055
Phone: 403-943-2528 | Fax: 403-943-4017
Phone: 403-956-2493 | Fax: 403-956-2994
Phone: 403-592-5049 | Fax: 403-244-5920
Phone: 403-270-7575 | Fax: 403-270-2164
Phone: 403-220-8457 | Fax: 403-592-5090
Phone: 403-944-8052 | Fax: 403-944-3001
Phone: 403-220-4245 | Fax: 403-283-5594
Phone: 403-220-4504 | Fax: 403-210-8723
Phone: 403-955-8661 | Fax: 403-944-3199
Phone: 403-955-8733 | Fax: 403-955-8199
Phone: 403-210-7736 | Fax: 403-283-6151
Phone: 403-220-8382 | Fax: 403-283-6151
Phone: 403-943-5526 | Fax: 403-943-4908
Phone: 403-210-8906 | Fax: 403-283-6151
Phone: 403-956-2401 | Fax: 403-956-3836
Assistant Dean of Research – Cumming School of Medicine, Professor
Phone: 403-220-8867 | Fax: 403-210-8113
Clinical Interests: Thyroid Gland Disorders and their treatments, Familial Hypercholesterolemia
Research Interests: Hormone action at the molecular level, Epigenetics, Treatment of Endocrine Diseases
Phone: 403-944-5246| Fax: 403-944-1647
Phone: 403-956-2466 | Fax: 403-956-2991
Phone: 403-943-8896 | Fax: 403-943-8535
Phone: 403-956-2466 | Fax: 403-956-3838
Phone: 403-943-5448 | Fax: 403-943-4017
Phone: 403-568-9789 | Fax: 403-590-8616
Her areas of practice include osteoporosis and metabolic bone disease (with clinics at the Dr David Hanley Osteoporosis Centre at the Richmond Road Diagnostic and Treatment Centre) as well as general diabetes, diabetes in pregnancy, and general endocrinology (with clinics at the Peter Lougheed Centre). She has research interests in diabetes in pregnancy and is also involved with teaching medical students and residents.
Phone: 403-804-2112 | Fax: 403-299-5800
Zone Clinical Section Chief – Gastroenterology, Professor
Phone: 403-592-5010 | Fax: 403-210-9345
Adjunct Associate Professor
Phone: 403-592-5015 | Fax: 403-592-5090
Phone: 403-956-2401 | Fax: 403-956-2995
Program Director – Internal Medicine Residency Program, Clinical Associate Professor
Phone: 403-944-5680 | Fax: 403-944-1095
Phone: 403-592-5020 | Fax: 403-592-5090
Phone: 403-944-3590 | Fax: 403-283-4657
Email: Melissa Will
Phone: 403-277-7321 | Fax: 403-277-7327
Phone: 403-220-7725 | Fax: 403-283-5666
Phone: 403-956-2468 | Fax: 403-956-2991
Phone: 403-220-6376 | Fax: 403-283-6151
Phone: 403-299-5833 | Fax: 403-299-5834
Phone: 403-220-8457 | Fax: 403-944-6548
Phone: 403-944-2667 | Fax: 403-944-5803
Email: Betty Murphy
Phone: 403-210-6251 | Fax: 403-210-8723
Phone: 403-592-5049 | Fax: 403-944-6559
Phone: 403-210-9421 | Fax: 403-283-1651
Phone: 403-220-6376 | Fax: 403-210-8723
Phone: 403-944-2325 | Fax: 403-944-3364
Phone: 403-220-6842 | Fax: 403-270-1828
Phone: 403-944-3590 | Fax: 403-944-4988
Phone: 403-944-8090 | Fax: 403-944-2134
Phone: 403-943-5423 | Fax: 403-943-5520
Phone: 403-943-8832| Fax: 403-943-8592
Phone: 403-955-8328 | Fax: 403-955-8249
Dr. Jennifer Yamamoto is currently a member of the Division of Endocrinology at the University of Calgary and is conducting her clinical work at the Richmond Road Diagnostic and Treatment Centre and the Foothills Medical Centre Diabetes in Pregnancy Clinic.
Her clinical expertise includes in diabetes in pregnancy, endocrine disorders in pregnancy and reproductive endocrinology. Dr. Yamamoto is currently completing her Masters in Clinical Epidemiology at the University of Calgary. Her primary research interest is in endocrine disorders in pregnancy and diabetes in pregnancy.
Phone: 403-944-8168 | Fax: 403-944-2876
Email: Kim Moccasin
Vice Chair – Physician Wellness, Clinical Professor
Phone: 403-943-8693 | Fax: 403-943-8535
Phone: 403-210-7369 | Fax: 403-283-6151
Phone: 403-220-5951 | Fax: 403-270-2772
Phone: 403-955-8660 | Fax: 403-955-8200
Zone Clinical Section Chief, Clinical Associate Professor
Phone: 403-955-8345 | Fax: 403-955-8200
Clinical Assistant Professor, Clinical Nephrologist
Phone: 403-210-8608 | Fax: 403-270-7307
Phone: 403-955-8733 | Fax: 403-955-8029
Phone: 403-955-1505| Fax: 403-955-1504
Areas of research interest: Health Economics, Diabetic Foot Disease, Endocrine Hypertension
Phone: 403-955-8748 | Fax: 403-955-8029
Phone: 403-944-1598 | Fax: 403-270-0055
Email: Freda Cook